Search

YSM Online

Features

Bull’s Eye: Targeted Immunotherapy of Myasthenia Gravis

Myasthenia gravis is a motor disease, starting with muscular pain and potentially escalating to failure of vital muscles such as the diaphragm. Like other autoimmune diseases, it was historically treated with steroids, which suppress the immune system overall. Professor Richard Nowak at the Yale School of Medicine has found a much more targeted attack strategy.

Read More »
90.1

Solid Evidence for Liquid Water on Dione

Data gathered by NASA’s Cassini mission suggests that liquid water is present on Saturn’s Dione, researchers reported in the journal Geophysical Research Letters in October 2016.

Read More »
90.1

Eczema Patients Have a Unique Microbiome

Patients with atopic dermatitis, also known as eczema, have a unique skin microbiome. Knowing more about the relationship between the microbiome and skin conditions like eczema could result in novel, targeted therapies.

Read More »
YSM Online

Unraveling the Mystery of Spirochete Growth

A recent study by Yale researchers found that Borrelia burgdorferi, the causative agent of Lyme disease, exhibits a unique pattern of cell growth, elongating through discrete “hot zones” of cell wall synthesis that mark where daughter cells will divide. This discovery could help yield new, targeted therapies for Lyme disease.

Read More »